The human homolog of RAD54, ATRX, was UES by PharmacoDB analysis (Figure 6D, 1-0-0), and loss of ATRX has been associated with improved response to gemcitabine plus radiation therapy in glioma patients with IDH1 mutations [168]. This evidence concerns the gene ATRX and glioma.